TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PCVX

Vaxcyte Inc

Healthcare · Biotechnology

58.10$ -3.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Vaxcyte Inc (PCVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 3,046 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PCVX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
40 71 66 393 324 1,006 1,408 3,511 3,046
36 67 62 389 256 943 1,096 1,788 1,627
36 66 59 386 69 835 397 388 174
36 66 59 386 246 931 1,080 1,747 1,561
0.2 0.3 1.2 1.0 3.6 21 47
-0.2 -0.3 -1.2 -1.0 -6.2
3.0 3.4 3.4 3.3 36 32
8.7 129 172 47 40 53 167 205 360
4.3 6.7 11 47 29 41 145 140 206
0.3 0.3 0.2 5.3 5.9 7.1 5.9 6.1
1.8 2.8 3.4 30 6.8 9.8 15 48 71
3.8 3.6 0.5
31 -58 -106 346 284 954 1,240 3,306 2,686
-30 -59 -109 -199 -299 -522 -924 -1,388 -2,155
3.6 26 49 30 52 65 97 122 136

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?